HIF1A and neoplasm: The results of the KEGG pathway enrichment analysis showed that the pathways related to potential therapeutic targets (excluding other disease pathways) mainly included the IL-17 signalling pathway, the TNF signalling pathway, and the HIF-1 signalling pathway, which have been associated with tumours [35–37].